Publication | Open Access
The combined impact of<i>CYP2C19</i>and<i>CYP2B6</i>pharmacogenetics on cyclophosphamide bioactivation
52
Citations
32
References
2010
Year
The presence of ≥1 LoF allele(s) at either CYP2B6 or CYP2C19 appeared to result in decreased bioactivation of cyclophosphamide both in vitro and in patients. Further clinical studies to confirm this relationship are warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1